An improved flow cytometric method using FACS lysing solution for measurement of ZAP-70 expression in B-cell chronic lymphocytic leukemia

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 1, 2008, Pages 40-44

  Bekkema, Roelof ^a   Tadema, Afke ^a   Daenen, Simon M G J ^a   Kluin Nelemans, Hanneke C ^a   Mulder, André B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

B CLL; FACS lysing solution; Flow cytometry; ZAP 70

Indexed keywords

PROTEIN KINASE ZAP 70; REAGENT;

ARTICLE; B CELL LEUKEMIA; BLOOD ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGEN-ANTIBODY REACTIONS; B-LYMPHOCYTES; CELL MEMBRANE PERMEABILITY; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; REAGENT KITS, DIAGNOSTIC; SOLUTIONS; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 38349080043     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20367     Document Type: Article

References (19)

1. Qian D, Lev S, van Oers NS, Dikic I, Sehlessinger J, Weiss A. Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. J Exp Med 1997;185:1253-1259.
2. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: A 70 kDa protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992;71:649-662.
3. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003; 101:4944-4951.
4. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukaemia. N Engl J Med 2003;348:1764-1775.
5. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic, leukaemia. Lancet 2004;363: 105-111.
6. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn LW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893-901.
7. Krutzik PO, Nolan GP. Intracellular phosphor-protein staining techniques for flow cytometry: Monitoring single cell signaling events. Cytometry Part A 2003;55A:61-70.
8. Gibbs G, Bromidge T, Howe D, Hopkins J, Johnson S. Comparison of How cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory. Clin Lab Haematol 2005;27: 258-266.
9. Titus K. Zigs and zags on the ZAP-70 highway. College of American Pathologists. CAP Today 2004:1-4.
10. Best OG, Ibbotson RE, Parker AE, Davis ZA, Orchard JA, Oscier DG. Zap-70 by flow cytometry: A comparison of different antibodies, anticoagulants, and methods of analysis. Cytometry Part B: Clin Cytometry 2006;70B:235-241.
11. Wilhelm C, Neubauer A, Brendel C. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied. Cytometry Part B: Clin Cytometry 2006;70B: 242-250.
12. H mutation analysis. Cytometry Part B: Clin Cytometry 2006;70B:270-275.
13. Letestu R, Rawstron A, Ghia P, Villamor N, Leuven NB, Boettcher S, Muhl AM, Duerig J, Ibbotson R, Kroeber A, Langerak A, Le Garff-Tavernier M, Mockridge I, Morilla A, Padmore R, Rassenti L, Ritgen M, Shehata M, Smolewski P, Staib P, Ticchioni M, Walker C, Ajchenbaum-Cymbalista F. on behalf of the ERIC (European Research Initiative in CLL) and the Leukemianet. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukaemia: A multicenter international harmonization process. Cytometry Part B: Clin Cytometry 2006;70B:309-314.
14. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. pp 127-130.
15. Shankey TV, Forman M, Scibelli P, Cobb J, Smith CM, Mills R, Holdaway K, Bernal-Hoyos E, Van der Heiden M, Popma J, Keeney M. An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukaemia. Cytometry Part B: Clin Cytometry 2006;70B:259-269.
16. Bakke AC, Purtzer Z, Leis J, Huang J. A robust radio metric method for analysis of ZAP-70 expression in chronic lymphocytic leukaemia (CLL). Cytometry Part B: Clin Cytometry 2006;70B:227-234.
17. Shenkin M, Maiese R. Use of a blocking antibody method for the flow cytometric measurement of ZAP-70 in B-CLL. Cytometry Part B: Clin Cytometry 2006;70B:251-258.
18. Nolz JC, Tschumpcr RC, Pittner BT, Darce JR, Kay NE, Jelinek DE. ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype. Leukemia 2005;19:1018-1024.
19. Cutrona G, Colombo M, Matis S, Reverberi D, Dono M, Tarantino V, Chiorazzi N, Ferrarini M. B lymphocytes in humans express ZAP-70 when activated in vivo. Eur J Immunol 2006;36:558-569.